Larimar Therapeutics Inc
LRMR
Market Cap$204.89M
Close$
$0.46
85.7% downside
Current Fair Value
85.7% downsideOvervalued by 85.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $204.89 Million |
|---|---|
| Enterprise Value | $188.63 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.32 |
| Beta | 0.79 |
| Outstanding Shares | 63,964,008 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.15 |
|---|---|
| PEG | -2.15 |
| Price to Sales | - |
| Price to Book Ratio | 1.6 |
| Enterprise Value to Revenue | 782.69 |
| Enterprise Value to EBIT | -1.79 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data